Cette page n’est pas encore disponible en français. La version anglaise est affichée.

ESPI 5/2023 · 23 Mar 2023

Completion of a significant stage of the market launch of the product offered by Vee Care sp. z o.o.

System
ESPI
Number
5/2023
Published
23 March 2023, 16:19 (Warsaw time)
Type
Current report
Category
Inside information
Legal basis
Art. 17(1) MAR – inside information.
Official language
Polish
This page
English translation for information; the Polish text is the official version

Translation for information. The official version of this report was published by Vee S.A. in Polish through ESPI on 23 March 2023, 16:19 (Warsaw time). In the event of any discrepancy, the official version published via ESPI prevails. Official version (Polski) · Official publication (PAP ESPI/EBI) ↗

Report text

The Management Board of Vee SA (hereinafter the "Company", the "Issuer") publishes information that the final stage of testing of the first of the modules of the Vee Health Suite product has been completed, i.e. the standard ("boxed") solution for the medical industry offered by the Issuer's subsidiary, Vee Care sp. z o.o. The first module relates to confirming and cancelling medical appointments. The Company announced its plans to make the product available in periodic report EBI 2/2023 for Q4 2022.

The product has been released for sale. The results of the first activities of the sales network will be observable in the second quarter of 2023 at the earliest.

At the same time, the Management Board informs that further modules of this product should be released for sale in the subsequent quarters of this year.

Attachments

This report has no attachments.